Trial · NCT07909044
Training, Coaching and Marketing Program for Vegetable and Fruit Vendors in Markets to Improve Food Safety Practices and Vegetable and Fruit Intake Among Women 20-49 yr Old in Quezon City, Philippines
NCT07909044, Not applicable, Recruiting, The International Livestock Research Institute (ILRI)
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Training, Coaching and Marketing Program for Vegetable and Fruit Vendors in Markets to Improve Food Safety Practices and Vegetable and Fruit Intake Among Women 20-49 yr Old in Quezon City, Philippines. Trials, record NCT07909044. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07909044
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Training, Coaching and Marketing Program for Vegetable and Fruit Vendors in Markets to Improve Food Safety Practices and Vegetable and Fruit Intake Among Women 20-49 yr Old in Quezon City, Philippines
- NCT number
- NCT07909044
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 1,143 participants, estimated
- Lead sponsor
- The International Livestock Research Institute (ILRI)
- Conditions
- Intake of Fruit, Intake of Vegetables, Food Safety
- Interventions
- Training, coaching and marketing program
- First posted
- 2026-11-02
- Last updated
- 2026-11-03
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Total daily intake (g/day) of fruits and vegetables by women 20-49 years old (age at baseline) | 12 months | |
| Primary | Total daily intake (g/day) of vegetables by women 20-49 years old (age at baseline) | 12 months | |
| Primary | Total daily intake (g/day) of fruits by women 20-49 years old (age at baseline) | 12 months | |
| Primary | Proportion of vendors reporting at least two new good food handling and safety practices | Baseline and 12 months | Uptake of a good practice means reported using a new practice at endline (12 months) that they were not using at baseline |
| Secondary | Mean probability of micronutrient adequacy (MPA) of women 20-49yr old at baseline | 12 months | For each of 11 key micronutrients (iron, calcium, zinc, vitamin A, thiamin, riboflavin, niacin, vitamin B-6, vitamin B-12, vitamin C, and folate) we will calculate the probability of adequacy using usual intake. The mean will be calculated across these 11 probabilities |
| Secondary | Global Diet Quality Score (GDQS) and subscales (GDQS+ and GDQS-) in women 20-49yr old (age at baseline) | 12 months | All foods and beverages reported will be categorized into 25 groups. The overall GDQS score ranges from 0 to 49, with higher scores indicating healthier food choices; GDQS+ (reflecting the intake of healthy foods) ranges from 0 to 32, and GDQS- (reflecting the intake of unhealthy goods) from 0 to 17. |
| Secondary | Business monthly profits of fruit and/or vegetable vendors | 12 months | Profit is calculated as the difference between the monthly fruit and/or vegetable revenue (i.e. income earned through sales) and monthly business expenses (i.e. including purchase of stock, costs of running the business). |
| Secondary | Proportion of vendors reporting at least two new good business practices | baseline and 12 months | Uptake of a good practice means reported using a new practice at endline (12 months) that they were not using at baseline |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07909044
GET https://conductscience.org/api/trials/v1/NCT07909044/registered